LCM
HALO icon

Laurion Capital Management’s Halozyme HALO Stock Holding History

Laurion Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-87,300
Closed -$753K – 992
2016
Q2 		$753K Hold
87,300
– – 0.01% 511
2016
Q1 		$827K Buy
+87,300
New +$821K 0.01% 461

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Laurion Capital Management's HALO Position: Q3 2025 in Review

Laurion Capital Management sold out of Halozyme (HALO) in Q3 2025, closing a stake of 12,267 shares — an estimated $638K sold.

Laurion Capital Management first reported a position in HALO in Q4 2014 and held it in 4 quarters. The position peaked at $638K in Q2 2025. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

  • Laurion Capital Management reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
  • Laurion Capital Management sold 12,267 Halozyme shares in Q3 2025, an estimated $638K.
  • Laurion Capital Management first reported a position in Halozyme in Q4 2014 and held it in 4 quarters.
  • Laurion Capital Management's Halozyme position peaked at $638K in Q2 2025.
  • 602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Laurion Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.